Clinical trial
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Recruiting now · Phase 2 · 2 countries · Registry ID NCT06143956
What this study is about
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.
Basic eligibility
Full registry criteria
Treatments and study arms
LY3305677
Administered SC. ISA specific interventions will be listed in the ISA.
LY3841136
Administered SC. ISA specific interventions will be listed in the ISA.
Tirzepatide
Administered SC. ISA specific interventions will be listed in the ISA.
LY3549492
Administered orally. ISA specific interventions will be listed in the ISA.
LY3532226
Administered SC. ISA specific interventions will be listed in the ISA.
Placebo
Administered SC. ISA specific interventions will be listed in the ISA.
Placebo
Administered orally. ISA specific interventions will be listed in the ISA.
Primary outcomes
Each ISA will detail the intervention specific analysis.
Study locations
56 locations were listed when this page was built. The first 40 are shown.